Literature DB >> 22669265

Transcatheter embolization of extensive left gastric artery collaterals presenting with massive upper gastrointestinal bleed.

Souheil Saddekni1, Ahmed Kamel Abdel-Aal, Rachel F Oser, Edgar Underwood, Asim Bag.   

Abstract

We report a case of extensive left gastric artery collaterals that were formed in the region of gastric fundus due to splenic artery occlusion and resulted in massive hematemesis. These collaterals were thought to be portosystemic collaterals related to portal hypertension during upper endoscopy study and single-phase venous computed tomography studies. The collaterals were treated by transcatheter endovascular coil embolization. Our case highlights the importance of recognizing and differentiating left gastric artery collaterals from gastric venous varices as a cause of hematemesis since the treatment approach for each condition is totally different. It also introduces the feasibility of percutaneous left gastric artery embolization as a treatment for this condition, without the need for surgical splenectomy and partial gastrectomy which have a higher mortality and morbidity.

Entities:  

Mesh:

Year:  2012        PMID: 22669265     DOI: 10.1177/1538574412449908

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Clinical application value of preoperative selective partial splenic embolization before splenectomy plus portal-azygous disconnection.

Authors:  Shengxing Zhu; Sheng Chang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Treatment of Hypersplenism by Partial Splenic Embolization Through Gastric Collaterals.

Authors:  Souheil Saddekni; Amr Soliman Moustafa; Hany A Tahoon; Mostafa Setita; Ahmed Kamel Abdel-Aal
Journal:  J Radiol Case Rep       Date:  2016-03-31

3.  Chronic splenic artery occlusion with gastric wall arterial ectasia, an unusual cause of massive upper gastrointestinal hemorrhage.

Authors:  Hassan Al-Balas; Zeyad A Metwalli; David M Sada
Journal:  BJR Case Rep       Date:  2021-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.